From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,575,692 shares, representing 4.52% for $11 million under the buyback announced on December 20, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 USD | 0.00% | 0.00% | -30.99% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.99% | 189M | |
+4.23% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Tranche Update on Zevra Therapeutics, Inc.'s Equity Buyback Plan announced on December 20, 2021.